These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 18047040)
21. Bovine serum albumin-coated ZIF-8 nanoparticles to enhance antitumor and antimetastatic activity of methotrexate: Salimi M; Adibifar A; Rostamkhani N; Karami Z; Agh-Atabay AH; Abdi Z; Rostamizadeh K J Biomater Sci Polym Ed; 2024 Oct; 35(15):2294-2314. PubMed ID: 39037940 [TBL] [Abstract][Full Text] [Related]
22. Layered double hydroxides - poloxamer 188 nanocomposites based on exfoliation reassembling for improved cellular uptake and controlled delivery of methotrexate. Liang L; Ren J; Dai J; Liu J; Zhang L; Li D; Yang C; Yu J Pharm Dev Technol; 2023 Oct; 28(8):743-754. PubMed ID: 37577952 [TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line. Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260 [TBL] [Abstract][Full Text] [Related]
24. Efficient drug delivery using SiO2-layered double hydroxide nanocomposites. Li L; Gu Z; Gu W; Liu J; Xu ZP J Colloid Interface Sci; 2016 May; 470():47-55. PubMed ID: 26930539 [TBL] [Abstract][Full Text] [Related]
25. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes. Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673 [TBL] [Abstract][Full Text] [Related]
26. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition. Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671 [TBL] [Abstract][Full Text] [Related]
27. Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier. Attari E; Nosrati H; Danafar H; Kheiri Manjili H J Biomed Mater Res A; 2019 Nov; 107(11):2492-2500. PubMed ID: 31298774 [TBL] [Abstract][Full Text] [Related]
28. Nanohybrid based on antibiotic encapsulated layered double hydroxide as a drug delivery system. Khan SB; Alamry KA; Alyahyawi NA; Asiri AM; Arshad MN; Marwani HM Appl Biochem Biotechnol; 2015 Feb; 175(3):1412-28. PubMed ID: 25399066 [TBL] [Abstract][Full Text] [Related]
29. The construction and characterization of layered double hydroxides as delivery vehicles for podophyllotoxins. Xue YH; Zhang R; Sun XY; Wang SL J Mater Sci Mater Med; 2008 Mar; 19(3):1197-202. PubMed ID: 17701296 [TBL] [Abstract][Full Text] [Related]
30. Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Kohler N; Sun C; Wang J; Zhang M Langmuir; 2005 Sep; 21(19):8858-64. PubMed ID: 16142971 [TBL] [Abstract][Full Text] [Related]
31. Enhanced colloidal stability and protein resistance of layered double hydroxide nanoparticles with phosphonic acid-terminated PEG coating for drug delivery. Cao Z; Adnan NNM; Wang G; Rawal A; Shi B; Liu R; Liang K; Zhao L; Gooding JJ; Boyer C; Gu Z J Colloid Interface Sci; 2018 Jul; 521():242-251. PubMed ID: 29574343 [TBL] [Abstract][Full Text] [Related]
32. Methotrexate loaded on magnetite iron nanoparticles coated with chitosan: Biosynthesis, characterization, and impact on human breast cancer MCF-7 cell line. Ali EMM; Elashkar AA; El-Kassas HY; Salim EI Int J Biol Macromol; 2018 Dec; 120(Pt A):1170-1180. PubMed ID: 30172815 [TBL] [Abstract][Full Text] [Related]
33. Engineered Cellular Uptake and Controlled Drug Delivery Using Two Dimensional Nanoparticle and Polymer for Cancer Treatment. Senapati S; Shukla R; Tripathi YB; Mahanta AK; Rana D; Maiti P Mol Pharm; 2018 Feb; 15(2):679-694. PubMed ID: 29298488 [TBL] [Abstract][Full Text] [Related]
34. Improvement of pharmacokinetic and antitumor activity of layered double hydroxide nanoparticles by coating with PEGylated phospholipid membrane. Yan M; Zhang Z; Cui S; Lei M; Zeng K; Liao Y; Chu W; Deng Y; Zhao C Int J Nanomedicine; 2014; 9():4867-78. PubMed ID: 25364245 [TBL] [Abstract][Full Text] [Related]
35. Biocompatible nanoparticles intercalated with anticancer drug for target delivery: pharmacokinetic and biodistribution study. Choi SJ; Oh JM; Choy JH J Nanosci Nanotechnol; 2010 Apr; 10(4):2913-6. PubMed ID: 20355523 [TBL] [Abstract][Full Text] [Related]
38. Drug-inorganic-polymer nanohybrid for transdermal delivery. Kim MH; Park DH; Yang JH; Choy YB; Choy JH Int J Pharm; 2013 Feb; 444(1-2):120-7. PubMed ID: 23357253 [TBL] [Abstract][Full Text] [Related]
39. Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer. Jain A; Sharma G; Kushwah V; Garg NK; Kesharwani P; Ghoshal G; Singh B; Shivhare US; Jain S; Katare OP Nanomedicine (Lond); 2017 Aug; 12(15):1851-1872. PubMed ID: 28703643 [TBL] [Abstract][Full Text] [Related]
40. Transferrin-oligomers as potential carriers in anticancer drug delivery. Lim CJ; Shen WC Pharm Res; 2004 Nov; 21(11):1985-92. PubMed ID: 15587919 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]